Table 3.
Subj | Sessions | TOVA | SCORE! | CC-TS | JLO | RCFC | RCFR | RAVLT-ACQ | RAVLT-A7 | RAVLT-RECOG | WJ-III UD | MAE- SR | Pegboard- Left | Pegboard- Right | FT-Left | FT-Right |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | 1 → 2 | 0.84 | −3.33 | 0.67 | 0.38 | 2.67 | 5.09 | −1.01 | −1.04 | 0 | 0.53 | −0.5 | 0.27 | 0.8 | 0.59 | 0.65 |
2 → 3 | 0.96 | 2 | 0.33 | 0.57 | −1.31 | −1.75 | 0.7 | 0.69 | 0.29 | −1.07 | −0.65 | 0.47 | 0.53 | 1.07 | 1.79 | |
2 | 1 → 2 | 1.92 | −1 | −0.67 | 0.19 | 0.8 | 1.36 | 1.6 | 0.5 | 1.25 | 0.4 | 1.05 | 0.2 | 0.53 | −0.36 | −0.66 |
2 → 3 | −3.66 | 1 | 2 | −0.54 | 1.66 | −0.23 | −0.54 | −0.5 | −0.84 | −0.53 | −0.26 | 0.33 | 0.4 | 0.92 | −0.21 | |
3 | 1 → 2 | −1.67 | −3.67 | −0.67 | 1.16 | 0.13 | −0.16 | −0.93 | −0.5 | −1.25 | 0.47 | 0.5 | 0.2 | −0.4 | 1.32 | 1.35 |
4 | 1 → 2 | −1.59 | 0 | 0.67 | −0.02 | 0.95 | 0.6 | −0.94 | −1.5 | 0 | 0.27 | 0 | −0.2 | 0.4 | 0.55 | 0.46 |
2 → 3 | 2.52 | 0 | 0 | 0.66 | 0.25 | 0.62 | −0.76 | −1.53 | 0.29 | 0.13 | −2.86 | 1.6 | 1.07 | 1.7 | 1.55 | |
5 | 1 → 2 | −4.84 | −3 | −0.33 | 1.58 | 0.75 | 1.35 | −0.2 | −0.71 | 1.25 | −0.13 | −2.42 | 0 | 1.87 | −0.49 | −1.06 |
2 → 3 | 4.57 | 0.33 | 2 | −0.4 | −0.34 | −1.28 | 1.8 | −1.42 | 0.37 | 1.26 | 1.01 | −0.4 | −0.2 | 0.26 | −0.04 | |
6 | 1 → 2 | * | −1.33 | 1.33 | −0.98 | 0 | 1.36 | 0 | −0.87 | 0 | −0.07 | −0.06 | 1.13 | 1.53 | 2.26 | 3.65 |
2 → 3 | * | 2.33 | 1 | 0.98 | 0.29 | 0.68 | 0.69 | 0 | −1.67 | 0.07 | −1 | 0.2 | 0.8 | −0.61 | −2.54 | |
Test-Retest Coeff. | 0.80 | 0.76 | 0.57 | 0.90 | 0.47 | 0.79 | 0.70 | 0.62 | 0.60 | 0.76 | 0.91 | 0.86 | 0.86 | 0.77 | 0.78 | |
Sig. Change | ±0.80 | ±0.96 | ±1.72 | ±0.40 | ±2.12 | ±0.84 | ±1.20 | ±1.52 | ±1.60 | ±0.96 | ±0.36 | ±0.56 | ±0.56 | ±0.92 | ±0.88 |
Notes: Test-Retest Coeff. = published test-retest coefficient; Sig. Change = Z-score change which has ≤ 5% probability of occurring, based on published test-retest coefficient. NT = Not tested for one of the sessions. NA = Not applicable. L = Left; R = Right; B = Bilateral.
Neuropsychological session-to-session change values marked in bold are those in which variability was considered significant.
TOVA could not be scored for Subject 6 in any of the three sessions due to high Intra-session trial-by-trial response variability.